Evotec AG (EVTCY) Set to Announce Earnings on Thursday
Evotec AG (OTCMKTS:EVTCY) is set to issue its quarterly earnings data before the market opens on Thursday, August 10th. Analysts expect the company to announce earnings of $0.07 per share for the quarter.
Evotec AG (OTCMKTS EVTCY) opened at 31.44 on Tuesday. The company has a market cap of $2.20 billion, a PE ratio of 53.29 and a beta of 0.59. The company’s 50-day moving average price is $30.50 and its 200-day moving average price is $23.11. Evotec AG has a 12-month low of $9.18 and a 12-month high of $33.13.
Evotec AG Company Profile
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners’ target through a range of commercial structures, including research fees, milestones and/or royalties.
Receive News & Ratings for Evotec AG Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec AG and related companies with MarketBeat.com's FREE daily email newsletter.